WO2013048140A3 - Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof - Google Patents

Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof Download PDF

Info

Publication number
WO2013048140A3
WO2013048140A3 PCT/KR2012/007817 KR2012007817W WO2013048140A3 WO 2013048140 A3 WO2013048140 A3 WO 2013048140A3 KR 2012007817 W KR2012007817 W KR 2012007817W WO 2013048140 A3 WO2013048140 A3 WO 2013048140A3
Authority
WO
WIPO (PCT)
Prior art keywords
nerve cells
composition
phragmitis rhizoma
rhizoma extracts
extracts
Prior art date
Application number
PCT/KR2012/007817
Other languages
French (fr)
Korean (ko)
Other versions
WO2013048140A2 (en
Inventor
정지훈
손원록
홍석명
Original Assignee
(주)솔빛피앤에프
주식회사 제노레버코리아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)솔빛피앤에프, 주식회사 제노레버코리아 filed Critical (주)솔빛피앤에프
Publication of WO2013048140A2 publication Critical patent/WO2013048140A2/en
Publication of WO2013048140A3 publication Critical patent/WO2013048140A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to Phragmitis Rhizoma extracts that can suppress variation in central nerves caused by an exposure to electromagnetic waves, and more particularly, to a functional food composition for suppressing damage to nerve cells caused by electromagnetic waves or a pharmaceutical composition for preventing and treating neurological disorders, containing Phragmitis Rhizoma extracts as active ingredients. The functional food composition or pharmaceutical composition, containing Phragmitis Rhizoma extracts, according to the present invention may suppress damage to nerve cells and therefore may be valuably used for purposes of preventing and treating neurological disorders.
PCT/KR2012/007817 2011-09-27 2012-09-27 Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof WO2013048140A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110097705A KR101203194B1 (en) 2011-09-27 2011-09-27 Inhibitory effect of Phragmitis Rhizoma extract on electromagnetic field-induced change in central nervous system
KR10-2011-0097705 2011-09-27

Publications (2)

Publication Number Publication Date
WO2013048140A2 WO2013048140A2 (en) 2013-04-04
WO2013048140A3 true WO2013048140A3 (en) 2013-05-23

Family

ID=47565058

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/007817 WO2013048140A2 (en) 2011-09-27 2012-09-27 Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof

Country Status (2)

Country Link
KR (1) KR101203194B1 (en)
WO (1) WO2013048140A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101818500B1 (en) * 2016-02-18 2018-01-15 한국 한의학 연구원 Composition for preventing, improviong or treating disease caused by side effect of anticancer agent comprising Phragmites communis Trin extract as effective component

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100285206B1 (en) * 1998-01-06 2001-03-15 황무연 Root extract and manufacturing method
KR20110020350A (en) * 2009-08-24 2011-03-03 최진호 A memory improving agent developed from components of red ginseng and reed root, a preparation method thereof, and food compositions enhanced functionality containing the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100285206B1 (en) * 1998-01-06 2001-03-15 황무연 Root extract and manufacturing method
KR20110020350A (en) * 2009-08-24 2011-03-03 최진호 A memory improving agent developed from components of red ginseng and reed root, a preparation method thereof, and food compositions enhanced functionality containing the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. JELENKOVIC ET AL.: "Effects of extremely low-frequency magnetic field in the brain of rats", BRAIN RESEARCH BULLETIN, vol. 68, 2006, pages 355 - 360, XP024900818 *
JIN-HO, CHOI ET AL.: "Effect of reed root extract(RRE) on learning and memory impairment animal model SAMP8 strain", KOREAN JOURNAL OF GERONTOLOGY, vol. 7, no. 3, 1997, pages 23 - 28 *

Also Published As

Publication number Publication date
KR101203194B1 (en) 2012-11-21
WO2013048140A2 (en) 2013-04-04

Similar Documents

Publication Publication Date Title
WO2014062691A3 (en) Compositions for modulating c9orf72 expression
PH12015500879A1 (en) Compositions and methods for treating proteinopathies
WO2012157978A3 (en) Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis
WO2012104007A3 (en) 7-azaindole derivatives
WO2011090270A3 (en) Composition containing osmotin for preventing and treating neurological disorders
MX2014010563A (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production.
WO2013119946A8 (en) Long chain base sphingosine kinase inhibitors
PH12017500706A1 (en) Composition containing extract or fraction of genus justicia plant
WO2011049327A3 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
SA113340494B1 (en) Composition for treating metabolic disorders
WO2014083422A3 (en) Treating soluble coffee
EP2575842A4 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
WO2013057592A3 (en) Treatment of sickle cell disease
EP2910247A4 (en) Compositions for preventing or treating allergic skin disorders, containing gpcr19 agents as active ingredients
WO2010009809A3 (en) Active substance combinations consisting of an anis fruit extract and hyaluronic acid
WO2012108749A3 (en) Composition and health functional food for treating brain cancer comprising pharbitidis semen extract
WO2016186349A3 (en) Composition, containing quisaqualis indica extract, for preventing or treating prostatic hyperplasia
WO2013000895A9 (en) Dha and epa in the reduction of oxidative stress
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
WO2012134172A3 (en) Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
WO2012108748A3 (en) Composition and cosmetic composition for treating brain cancer comprising albizzia julibrissin extract
WO2013048140A3 (en) Composition for suppressing nerve cells, containing phragmitis rhizoma extracts, and use thereof
WO2011112002A3 (en) Composition for treating, preventing or relieving macular degeneration, containing vaccinium uliginosum extract or vaccinium uliginosum fractions as active ingredient
WO2013005956A3 (en) Pharmaceutical composition and food composition for preventing and ameliorating intestinal motility disorders
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12836667

Country of ref document: EP

Kind code of ref document: A2